1. Home
  2. CMRE vs XNCR Comparison

CMRE vs XNCR Comparison

Compare CMRE & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costamare Inc. $0.0001 par value

CMRE

Costamare Inc. $0.0001 par value

N/A

Current Price

$15.37

Market Cap

1.9B

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$27.91

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMRE
XNCR
Founded
1974
1997
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
CMRE
XNCR
Price
$15.37
$27.91
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$12.00
$22.33
AVG Volume (30 Days)
324.0K
1.3M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
N/A
$125,576,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.80
P/E Ratio
$5.55
N/A
Revenue Growth
N/A
13.65
52 Week Low
$10.84
$7.91
52 Week High
$18.06
$30.61

Technical Indicators

Market Signals
Indicator
CMRE
XNCR
Relative Strength Index (RSI) 54.31 65.43
Support Level $15.16 $11.20
Resistance Level $15.86 $30.61
Average True Range (ATR) 0.44 1.54
MACD 0.06 -0.09
Stochastic Oscillator 73.33 66.83

Price Performance

Historical Comparison
CMRE
XNCR

About CMRE Costamare Inc. $0.0001 par value

Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: